Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Dipak Kotecha , Afzal Sohaib Added: 5 years ago
Dr Afzal Sohaib spoke with Dr Dipak Kotecha about the FAST trial - Thoracoscopic vs catheter ablation for atrial fibrillation Fillmed by Radcliffe Cardiology on-site at EHRA 2018 in Barcelona, ES View more
Added: 1 year ago
Complete LAA exclusion (LAAE) should always be part of any discussion about management of AF patients undergoing cardiac surgery. And here’s why… Thrombus in the LAA is believed to be the primary cause of stroke in AF patients1-3 LAAE has been shown to reduce stroke and bleeding risk1,4-6,9 Expert consensus supports the use of LAAE during concomitant cardiac surgery1,7,8 … View more
Author(s): Theodoros A Zografos , Demosthenes G Katritsis Added: 3 years ago
Atrial Fibrillation(AF) affects 1-2 % of the population, and its prevalence is expected to increase in the next 50 years.1,2 The treatment of these patients includes either restoration and maintenance of sinus rhythm (SR) or control of the ventricular rate.3 Electrical cardioversion (ECV) can be effective in restoring SR in the majority of patients; however, it is associated with several risks… View more
Author(s): Farhan Shahid , Gregory YH Lip Added: 3 years ago
Atrial fibrillation (AF) and heart failure (HF) are global epidemics that began more than a century ago, and their association with an ageing general population has brought about an increase in cardiovascular morbidity and rising healthcare costs.1,2 More than 50 % of patients with permanent AF have a concurrent diagnosis of HF and this proportion is expected to rise.3 It is well established that… View more
Author(s): Georgios Giannopoulos , Spyridon Deftereos Added: 3 years ago
Dear Sir, We read with great interest the meta-analysis by Pearman et al.1 on the comparison between epicardial ablation for atrial fibrillation and the hybrid approach. The authors should be commended on the way they handled the data. The imbalance between the two meta-analytic cohorts – in terms of the type of atrial fibrillation and left atrial diameter – may have worked to the detriment of… View more
Author(s): Amir A Schricker , Junaid Zaman , Sanjiv M Narayan Added: 3 years ago
Catheter ablation is more effective than pharmacological therapy for the secondary prevention of patients with paroxysmal1,2 and persistent3,4 atrial fibrillation (AF) and has an emerging role in the primary prevention of paroxysmal AF.5,6 Nevertheless, in randomised clinical trials (RCTs) its success in treating patients with paroxysmal AF is 40–60% for a single procedure and 70% for multiple… View more